Emanuele Arca is an Research Consultant in Strategic Market Access, located in OPEN Health’s Rotterdam office. His main expertise is conducting (systematic) literature reviews to inform network meta-analyses, global value dossiers and reimbursement dossiers. Moreover, Emanuele has experience in conducting stakeholder interviews and health policy impact evaluation.

His background is in European Public Health, he particularly focused on literature reviews in epidemiology and disease burden in EU countries and on EU functioning and policy-making in the field of healthcare. He has been involved in stakeholder analysis projects, where he conducted literature review and stakeholder interviews on the functioning of Public-Private-Partnerships in healthcare. Disease areas he has worked in include inflammatory disease, digestive conditions, oncology, and orphan diseases. He holds a M.Sc. degree in Health Economics, Policy and Law from Erasmus University in Rotterdam.

Sonika Awasthy is an Associate Director in Strategic Market Access, located in the London, UK office. Sonika has been working in market access consultancy for the last 6 years and joined OPEN Health in 2018.​

Sonika has a wealth of experience, providing payer research and market access advice to clients, including pricing and reimbursement strategies, landscape assessments, value message testing, advisory boards, evidence generation planning, reimbursement benchmarking, in-licensing opportunities and pathway tools. Her experience spans a vast range of disease areas from diabetes to oncology and from orphan diseases to biosimilars.​ With experience from a global payer perspective, more notably EU5 & US across a range of disease areas, Sonika is well-placed to provide expert consulting advice on issues of market access, reimbursement and pricing.​ Sonika has a Masters in International Health Management from Imperial College London.​

Lohit Badgujar is a Consultant in Strategic Market Access, located in the Mumbai, India office. He is an expert in conducting and managing the systematic literature review (SLR), which has been used to develop the HTA submission (NICE, CADTH), indirect treatment comparison (MAIC, NMA), global value dossier, and economic models.

Lohit also contributed to developing cost-effectiveness analysis, budget impact analysis, meta-analysis, and RWE compendium. Prior to joining OPEN Health, Lohit worked as a Manager, Value & Access, at Novartis, India, where he was supporting Market Access initiatives through evidence development and health economic modeling across the product life cycle. Additionally, Lohit served as a Director, ISPOR Mumbai Chapter from 2015 to 2016, where he was involved in training and educating students from the University of Mumbai and nearby geography. Lohit has presented his work at several international conferences and has publications in peer-reviewed journals. Lohit holds a Ph.D. (Tech) in Pharmacology from the University of Mumbai, Mumbai, and an M. Pharm. in Pharmacology from the Bharati Vidyapeeth University, Pune.

Kavitha Baruah is a Scientific Consultant in Strategic Market Access, located in the Marlow, UK office. Kavitha has experience working on market access deliverables including global evidence dossiers, systematic literature reviews, HTA strategy and stakeholder mapping across therapy areas. Kavitha also has extensive experience in designing and publishing RWE studies.​

Before joining OPEN Health, Kavitha worked on private consultancy projects conducting systematic literature reviews and spent several years working as a research academic authoring a number of research publications including book chapters on therapeutic antibodies. ​ Kavitha completed her DPhil in Biochemistry from the University of Oxford in 2012.​

Mark Bernauer, is an Associate Director in Strategic Market Access, located in the Bethesda, MD office. He has more than 25-years of experience across a breadth of roles including medical functions within the pharmaceutical industry, as a healthcare consultant, and as a registered pharmacist. His expertise includes medical writing (e.g., systematic and targeted literature reviews, manuscript development, and global and AMCP product-value dossiers), communication and evidence generation plans, market access recommendations, value propositions, and conducting competitor and stakeholder analyses. Mark has therapeutic experience in the following areas: neurology, dermatology, endocrinology, immunology, oncology, pulmonology, ophthalmology, and infectious disease.

Prior to joining OPEN Health, Mark worked within the consulting industry at Precision Health Economics and Optum across a variety of medical writing/market access projects. Mark also worked in the pharmaceutical industry at Eli Lilly and Company in Indianapolis, IN, primarily supporting the neuroscience portfolio, across a breadth of roles including health economics and outcomes research, medical sourcing, clinical plans and operations, and medical information. Mark has been responsible for creating and publishing over 15 manuscripts, conducting 50 plus literature reviews, and creating over 25 dossiers. Additionally, Mark served and led projects on the AMCP special projects committee. Mark earned his Bachelor of Pharmacy degree from the University of Wisconsin.

Tom Blaikie is a Director in Strategic Market Access, located in the London, UK office. Tom has been working in market access consultancy for the last 7+ years and joined OPEN Health in 2018.​

As an HTA lead, the core focus of Tom’s work is leading and developing strategic programmes of support for UK and European HTA submissions. This includes bringing together stakeholder engagement, literature reviews, HE modelling and dossier development to support the efficient and successful reimbursement of drugs and medical devices.​

Furthermore, Tom has experience delivering a wide range of global market access projects, including value propositions, advisory boards, landscape and analogue assessments, health economic models, client workshops and trainings, and digital communication platforms. He has considerable experience in a variety of therapy areas, including Oncology, Nephrology and Respiratory Medicine.​

Tom has a Masters in Chemistry from Jesus College, Oxford.​

Nikolina Boskovic, is a Research Analyst in Strategic Market Access, located in the Boston, MD office. Her expertise includes public health and global health research, systematic literature reviews, and manuscript and abstract development. Nikolina has therapeutic experience in the following areas: maternal and child health, circulatory disease.

Prior to joining OPEN Health, Nikolina held a Fulbright Fellowship in Belgrade, Serbia, researching pricing and reimbursement policies in the Balkans. She previously interned at HealthMap at Boston Children’s Hospital and People that Deliver Coalition in Denmark. Additionally, Nikolina served and led projects on the Pharmaceutical Program Leadership Committee at Boston University School of Public Health. Nikolina holds a Master of Public Health in Global Health and Graduate Certificate in Pharmaceutical Development, Delivery, and Policy from Boston University School of Public Health.

John Carter is a Director in Strategic Market Access and Modeling and Meta-Analysis located in the Bethesda, MD office.

John has worked for over 12 years in health economics and outcomes research focusing primarily on pharmacoeconomic and epidemiologic modeling. His responsibilities involve design, execution, and overall management of research and policy initiatives supporting market-access, regulatory, and core scientific objectives. Other projects commonly include predictive modeling, developing population management tools, and meta-analysis. John has a BA in Psychology from Loyola University in Maryland and an MS in Predictive Analytics from Northwestern University.

Chinenye Chukwu is a Research Analyst in Strategic Market Access. Her expertise includes synthesizing evidence through primary and secondary research to inform marketing and communication strategies. Chinenye has therapeutic experience in the following areas: diabetes and sickle cell disease.

Prior to joining OPEN Health, Chinenye worked as a Research Coordinator at a global marketing firm across a breadth of roles including moderating stakeholder interviews, conducting targeted literature reviews, managing and submitting IRB packages, and data analysis. Additionally, Chinenye contributed to the development of research plans and has led reports and presentations on various projects. Chinenye holds a Bachelor of Science degree from Rutgers University and a Master of Public Health degree from New York University with a concentration in Global Health.

Tash Cornwell is an Associate Market Access Consultant in the Strategic Market Access team, located in London. Tash joined OPEN Health in 2019 and completed the 18-month OPEN Health Graduate Development Program, gaining experience working in Medical Communications, Patient and Brand Communications and Market Access​. Tash joined the Strategic Market Access team full in March 2021.

Tash has experience working on ABNs, formulary guides, PIM/EAMS submissions, HTA dossiers, value propositions and global educational training programs across a range of therapy areas, with a focus on oncology and immunology. Tash supports the team with project management, finances, recruitment, and developing strategic market access materials.​

​Tash holds an MSc in Global Pharmacy and a first-class honors BSc in Neuroscience from the University of Nottingham. During Tash’s MSc research project, she investigated the barriers and facilitators in the supply and administration of IPTp for malaria during pregnancy in Lusaka, Zambia. She interviewed key healthcare workers across hospitals in Lusaka to gain best practice insights to support patient access and implementation of the antimalarial treatment.

Sarah Criddle, is a Senior Research Analyst in Strategic Market Access, located in the Bethesda, MD office. Her expertise includes drug information with a focus in medication safety and communications. Dr. Criddle has therapeutic experience in the following areas: endocrinology, psychology, infectious diseases, and oncology.

Prior to joining OPEN Health, Dr. Criddle was enrolled in the PharmD program at the Medical University of South Carolina (MUSC). She worked as a licensed pharmacy technician until she was accepted into MUSC and became an intern. As a pharmacy intern, she took lead to initiate medication therapy management services and vaccination services within MUSC Family Medicine Pharmacy. While completing her advanced pharmacy practice experiences, Dr. Criddle enhanced her knowledge in hospital administration, health economics and outcomes research, diabetes education, and psychiatric treatment, and administered COVID-19 vaccines as an American Pharmacists Association (APhA) certified immunizer. Additionally, she co-authored a publication on the association between potentially inappropriate medications and hospitalizations in older adults. Dr. Criddle earned her PharmD degree from the Medical University of South Carolina in May of 2021.

Catherine Daly is a Senior Consultant in Strategic Market Access, located in the London, UK office. She joined OPEN Health in 2020 and has worked within market access and commercial strategy consultancy for over 5 years. ​ ​

Prior to entering the field of market access, she worked for GlobalData- a Business Intelligence company as a senior ophthalmology and neurology analyst conducting in-depth market analysis and forecasting​. ​

Catherine has experience delivering a wide range of global market access projects, including pricing & reimbursement strategy, payer value communications and education tools, landscape assessments, value added services and digital solutions, stakeholder insights, patient pathway mapping and stakeholder mapping. Her experience covers multiple therapeutic areas across both pharmaceuticals and medical devices, including diabetes, neurosciences, ophthalmology, immunology, gastroenterology and cardiovascular medicine.

Catherine holds a PhD in molecular biology and genetics from University College, Dublin, and conducted postdoctoral research within a neurodevelopmental centre at Kings College London. Catherine holds a BSc in Biochemistry from University College Cork​.